Carole Verhoeven
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study.
Journal: Expert review of vaccines
Published: April 08, 2025
A randomized trial comparing safety, immunogenicity and efficacy of self-amplifying mRNA and adenovirus-vector COVID-19 vaccines.
Journal: NPJ vaccines
Published: April 05, 2024
Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study.
Journal: Vaccine
Published: October 14, 2022
Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial.
Journal: The Lancet. Infectious diseases
Published: January 10, 2022
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study.
Journal: The Lancet. Infectious diseases
Published: April 10, 2020
Pro-Apoptotic Effects of Estetrol on Long-Term Estrogen-Deprived Breast Cancer Cells and at Low Doses on Hormone-Sensitive Cells.
Journal: Breast cancer : basic and clinical research
Published: March 20, 2019
A Dose-Escalating Study With the Fetal Estrogen Estetrol in Healthy Men.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 18, 2018
Pharmacodynamic effects of the fetal estrogen estetrol in postmenopausal women: results from a multiple-rising-dose study.
Journal: Menopause (New York, N.Y.)
Published: February 08, 2017
The use of high-dose estrogens for the treatment of breast cancer.
Journal: Maturitas
Published: September 01, 2016
Last Updated: 09/26/2026